Global Neurological Disease Model Chip Market Growth 2024-2030

Global Neurological Disease Model Chip Market Growth 2024-2030

The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.

The global Neurological Disease Model Chip market size is projected to grow from US$ 53.6 million in 2024 to US$ 86.8 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Neurological Disease Model Chip Industry Forecast” looks at past sales and reviews total world Neurological Disease Model Chip sales in 2023, providing a comprehensive analysis by region and market sector of projected Neurological Disease Model Chip sales for 2024 through 2030. With Neurological Disease Model Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Disease Model Chip industry.

This Insight Report provides a comprehensive analysis of the global Neurological Disease Model Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Disease Model Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Disease Model Chip market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Disease Model Chip and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Disease Model Chip.

The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Disease Model Chip market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Neuron Chip
Brain Chip
Brain Organ Chip

Segmentation by Application:
Pharmaceutical R&D
Neuroscience Research
Clinical Diagnosis

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Emulate
CN Bio
TissUse
AxoSim Technologies
Nortis
Mimetas
SynVivo
Axion Biosystems
Tara Biosystems
InSphero
Hesperos
Kugelmeiers
Ascendance Biotechnology
BioIVT
BGI Genomics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neurological Disease Model Chip market?

What factors are driving Neurological Disease Model Chip market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neurological Disease Model Chip market opportunities vary by end market size?

How does Neurological Disease Model Chip break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver. Show more